Showing 97–108 of 140 results

Show sidebar
Show 9 12 18 24
Compare

Symdeko* (tezacaftor / ivacaftor)

£48,126.00
Symdeko (tezacaftor/ivacaftor)* is a medicine for the treatment of patients with cystic fibrosis (CF) aged 6 years and older. It is available in tablet form each containing 100 mg of tezacaftor and 150 mg of ivacaftor. It is indicated in combination with another medicine containing 150 mg ivacaftor alone. It is commercialized in Europe under the brand name Symkevi and in United States under the brand name Symdeko.
Add to wishlist
Select options
Quick view
Compare

Symkevi* (tezacaftor/ivacaftor)

£6,996.95
Symkevi (tezacaftor/ivacaftor)* is a medicine for the treatment of patients with cystic fibrosis (CF) aged 12 years and older. It is available in tablet form each containing 100 mg of tezacaftor and 150 mg of ivacaftor. It is indicated in combination with another medicine containing 150 mg ivacaftor alone. It is commercialized in Europe under the brand name Symkevi and in United States under the brand name Symdeko.
Add to wishlist
Select options
Quick view
Compare

Tagrisso (osimertinib)

£4,858.03
Tagrisso (osimertinib) is a medicine for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with a T790M mutation in the epidermal growth factor receptor (EGFR) gene.
Add to wishlist
Select options
Quick view
Compare

Takhzyro (lanadelumab)

£9,800.00
Takhzyro (lanadelumab) is a medicine for the prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. It is available as solution for injection in single-dose, ready-to-use vial.
Add to wishlist
Select options
Quick view
Compare

Taltz (ixekizumab)

£1,885.00
Taltz (ixekizumab) is a medication used for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.
Add to wishlist
Add to cart
Quick view
Compare

Taltz (ixekizumab)

£3,185.16 – £5,033.81
Taltz (ixekizumab) is a medication used for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.
Add to wishlist
Select options
Quick view
Compare

Tarpeyo (budesonide)

£13,607.00
Tarpeyo (budesonide) is a medication used to reduce proteinuria in adults with a kidney disease called primary immunoglobulin A nephropathy (IgAN).
Add to wishlist
Select options
Quick view
Compare

Tecentriq (Atezolizumab)

£4,452.90
Tecentriq (atezolizumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma, for the treatment of metastatic non-small cell lung cancer (NSCLC), and for the treatment of advanced triple negative breast cancer (TNBC).
Add to wishlist
Select options
Quick view
Compare

Tecfidera (dimethyl fumarate)

£1,168.56
Tecfidera (dimethyl fumarate) is a medication used for the treatment of multiple sclerosis (MS).
Add to wishlist
Select options
Quick view
Compare

Tepezza (teprotumumab-trbw)

£23,429.13
Tepezza (teprotumumab-trbw) is a medication for the treatment of active thyroid eye disease (TED), also called Grave’s eye disease.
Add to wishlist
Select options
Quick view
Compare

Tibsovo (ivosidenib)

£27,631.80
Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have:
  • Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or
  • Locally advanced or metastatic bile duct cancer (cholangiocarcinoma)
Add to wishlist
Select options
Quick view
Compare

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)

£923.00
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a medication used for the long term, maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) and asthma.
Add to wishlist
Select options
Quick view